Navigation Links
New strategy could uncover genes at the root of psychiatric illnesses
Date:7/10/2014

of Medicine. The researchers' strategygenerating disease-specific nerve cells, identifying a causative gene for developmental defects, validating the gene-specific defect in animal models, and then investigating interactions with other genes both in animal models and in humansrepresents a promising new approach for understanding the mechanisms underlying some of the most intractable psychiatric illnesses.

The work also highlights the promise of iPSC technology as a discovery tool in understanding and treating human disorders. "Despite an enormous amount of time and resources devoted to producing solid, reproducible results in animal models, far too often, results from preclinical trials deviate from our expectations," says co-author Dr. Hongjun Song. "The lack of access to disease-relevant human cell types has been a missing link in our current drug discovery process, which has now been resolved through advances in cellular reprogramming."


'/>"/>

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. WaferGen Reports Third Quarter 2011 Financial Results and Announces New Commercialization Strategy
2. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
3. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
4. SPO Updates Shareholders on 2012 Corporate Strategy
5. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
6. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
7. New gene therapy strategy boosts levels of deficient protein in Friedreichs ataxia
8. Womens Health Expert GC-Rise Ties up with Georgetown MBA Team to Tap M&A Potential and Growth Strategy
9. ASAE, TMG Custom Media Collaborate to Launch New Print-Plus-Digital Strategy for Associations Now Magazine
10. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
11. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New strategy could uncover genes at the root of psychiatric illnesses
(Date:9/4/2015)... ... September 04, 2015 , ... November Research ... services and software tools to pharmaceutical and life sciences organizations, today announced the ... Mobile is a mobile data intake solution that enables field sales representatives, clinical ...
(Date:9/3/2015)...  Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical ... Herbert Fritsche , Ph.D., the Lab Director of ... of the 2015 Abbott Award, given by the International ... to the field of basic or clinical oncology. Dr. ... in Zakopane, Poland . Prior ...
(Date:9/3/2015)... ... 03, 2015 , ... Park Systems announced that they will host ... 9am PST. The webinar will focus on the methods and materials for additive manufacturing ... manufacturing is a broad term that encompasses “addition or fusion” of materials to create ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 /PRNewswire/ ... has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. ... the pharmaceutical and biotechnology industries is anticipated. ... of drug development - from formulations for ...
Breaking Biology Technology:November Research Group’s PRIMO Mobile Goes Live at Allergan Japan 2Vermillion Announces Dr. Herbert Fritsche as Recipient of the 2015 Abbott Award from the International Society of Oncology and Biomarkers 2Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 2Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 3Park Systems Announces Webinar on 3D Printing and Additive Manufacturing for Nano-Scientists, Researchers in Nanotechnology and Engineers 4Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3
... market, EDMONTON, Aug. 27 /PRNewswire/ - Small ... bring nanotechnology products to,world markets can now access ... centre in Edmonton,s Research Park., The Alberta ... supported by $11.5 million in total funding with,contributions ...
... to put auto-injectable ... supplies list, SILVER SPRING, Md., Aug. 27 A ... found that 72% of school,nurses have students with a known ... not provided the school with auto-injectable,epinephrine. Also known as adrenaline, ...
... relapse, with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic ... filings, - Historically, one ... ... therapeutic approaches to patients with rare diseases, EAST ...
Cached Biology Technology:New nanotechnology centre helps turn big ideas into real products 2New nanotechnology centre helps turn big ideas into real products 3Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 2Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 3Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School 4Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 2Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 3Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 4Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 5Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 6Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 7Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 8Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 9Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 10Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 11Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery 12
(Date:8/6/2015)... CITY, Calif. , Aug. 6, 2015 /PRNewswire/ ... Valley) will visit Crossmatch ™ to learn ... networks and protect data. Crossmatch is a world ... whose technologies and expertise are helping federal agencies ... efficiency and security.   "The vast ...
(Date:8/5/2015)... Calif. , Aug. 5, 2015 The ... continuous growth in applications, penetration into newer sectors, and ... year. The global biosensors space has seen the entry ... the market so far. (Photo - ... & Sullivan, Analysis of the Global Biosensors Market ...
(Date:7/31/2015)... China , 31 de julio de 2015 /PRNewswire/ ... Genómica (ICG-10,  www.icg-10.org ) del 22 al 25 de ... . La conferencia celebra su décimo aniversario ... ha convertido en una de las reuniones anuales más ... y es una de las conferencias científicas más dinámicas, ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... technique for reprogramming human adult cells could greatly improve the ... in a range of therapeutic applications to repair or replace ... is published in the peer-reviewed journal Cellular Reprogramming , ... free online. Stem cells offer great promise ...
... available in French . , Eradicating smallpox was ... but new research shows initiatives of this kind are not ... think. McGill University Biologist Dr. Jonathan Davies explains that reducing ... is a far more effective and efficient strategy than trying ...
... found in both coconut oil and human breast milk ... thanks to a bioengineering graduate student from the UC San ... delivery system" published in the journal ACS Nano ... directly to skin-dwelling bacteria ( Propionibacterium acnes ) that cause ...
Cached Biology News:Novel strategy for generating induced pluripotent stem cells for clinical use is safe and efficient 2Trying to eradicate a disease is a waste of money: researcher 2Treat acne with coconut oil and nano-bombs 2
SCP-1 (P-17)...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biotin d anti-mouse Tim-1...
Mouse monoclonal [MLM544] to cardiac Myosin light chain 1 ( Abpromise for all tested applications). entrezGeneID: 4634 SwissProtID: P08590...
Biology Products: